Abstract: Introduction: ALK rearrangement in lung cancer has been identified as a novel molecular target in lung adenocarcinoma. In this study, we evaluated metabolic and metastatic features of lung adenocarcinoma by using FDG PET/CT, with regard to specific genotypes of ALK and EGFR mutation.Methods: Patients with lung adenocarcinoma initially diagnosed and examined with FDG PET/CT and molecular...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Metabolic and metastatic characteristics of ALK-rearranged lung adenocarcinoma on FDG PET/CT
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account
account